Sarepta Therapeutics Reports Long-Term Outcomes from Phase IIb Study of Eteplirsen

Disease: 
Link: 
Time Stamp: 
0
Thumbnail: 
https://mda_assets.s3.amazonaws.com/PR/2014/sarepta-sm.png